Cue Biopharma, Inc.

Home » Cue Biopharma, Inc.

IPO

Cue Biopharma, Inc.

They are an innovative biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.

Symbol

CUE

Price Range
$7.50 - $7.50

Anticipated Shares
8,000,000

Anticipated Date
TBD

Underwriters
MDB Capital, Feltl and Company

To view the prospectus for Cue Biopharma, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253